STOCK TITAN

Insider plans 709-share sale in issuer (INSM) under Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider has filed a Rule 144 notice to sell 709 shares of common stock through broker Merrill Lynch on or about 01/07/2026, to be traded on NASDAQ. These 709 shares were acquired on 01/05/2026 through stock plan activity with the issuer. The notice also lists prior sales over the last three months by the same seller, including 1,396 common shares sold on 01/06/2026 for gross proceeds of 241968, and 27,130 common shares sold on 11/03/2025 for gross proceeds of 4985054. By signing, the seller represents that they are not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many INSM shares are planned to be sold under this Form 144?

The notice covers a planned sale of 709 shares of common stock through Merrill Lynch on or about 01/07/2026, to be traded on NASDAQ.

How did the insider acquire the INSM shares being sold in this Form 144?

The 709 shares of common stock were acquired on 01/05/2026 via stock plan activity from the issuer, with the acquisition and payment both dated 01/05/2026.

What INSM share sales has the insider made in the last three months?

In the past three months, the seller reported two transactions: 1,396 common shares sold on 01/06/2026 for gross proceeds of 241968, and 27,130 common shares sold on 11/03/2025 for gross proceeds of 4985054.

Which broker and exchange are involved in this INSM Form 144 sale?

The planned sale of 709 INSM common shares is to be executed through Merrill Lynch, with the securities listed for trading on NASDAQ.

What representation does the insider make when signing this INSM Form 144?

By signing, the seller represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.

Does the INSM Form 144 mention Rule 10b5-1 trading plans?

The notice explains that if the seller relies on a written trading plan or instructions under Rule 10b5-1, by signing and indicating the adoption date they make the same representation as of that plan or instruction date.

Insmed Inc

NASDAQ:INSM

INSM Rankings

INSM Latest News

INSM Latest SEC Filings

INSM Stock Data

31.69B
211.09M
Biotechnology
Pharmaceutical Preparations
Link
United States
BRIDGEWATER